Heidi Schwarzenbach
Has participated in:
-
Establishment of new assays of exosome purification and microRNA isolation and quantification
-
LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
-
The effects of electromagnetic fields on breast cancer cell lines AND exosomal microRNAs in blood of breast cancer patients
-
Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression